News about "Pharma Acquisition "

NATCO Pharma Acquires Additional 13.25 Percent Stake in Adcock Ingram

NATCO Pharma has completed the acquisition of an additional 13.25 percent stake in South Africa's Adcock Ingram, strengthening its strategic investment in the pharmaceutical company.

Pharma Acquisition | 15/07/2026 | By News Bureau |  139

Sun Pharma to Acquire Innovcare Lifesciences in INR 271 Crore Strategic Deal

Sun Pharma will acquire Innovcare Lifesciences for INR 271.2 crore, strengthening its presence in pharmaceuticals, nutraceuticals, and cosmeceuticals through the acquisition of the Mumbai-based healthcare company.

Pharma Acquisition | 22/06/2026 | By News Bureau

Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription

Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).

Pharma Acquisition | 20/05/2026 | By News Bureau |  164

Octane Medical Group to Acquire Personalised Medicine Unit from Lonza

Octane Medical Group has signed an agreement to acquire the personalised medicine business of Lonza, including the Cocoon cell-therapy platform. The deal aims to expand Octane’s capabilities in advanced therapies and strengthen its presence in the rapidly growing personalised medicine sector.

Pharma Acquisition | 06/03/2026 | By News Bureau |  228

Worldwide Clinical Trials to Acquire Catalyst Clinical Research

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.

Pharma Acquisition | 21/01/2026 | By News Bureau |  337

Bayer to Enter Molecular Imaging, Acquires Pan-Amyloid Radiotracers from Attralus

By acquiring AT-01 and AT-05 from Attralus, Bayer strengthens its molecular imaging and cardiovascular precision medicine portfolio, targeting earlier and more accurate diagnosis of amyloidosis.

Pharma Acquisition | 14/01/2026 | By News Bureau |  246

Aurobindo Pharma Extends Timeline for Acquisition of Stake in Swarnaakshu Solar Power

Aurobindo Pharma has announced that the completion of its captive solar power purchase agreement and the acquisition of up to a 26 percent stake in Swarnaakshu Solar Power has been deferred to March 31, 2026, due to pending state government approvals for setting up the solar power plant.

Pharma Acquisition | 30/12/2025 | By News Bureau |  322

Exyte Completes Pharmaplan's Integration

The completed integration of Pharmaplan marks a major milestone in Exyte’s strategy to build a leading European player in life sciences engineering and strengthen collaboration with the region’s biotechnology and pharmaceutical industries.

Pharma Acquisition | 28/11/2025 | By Dineshwori |  318

PerkinElmer to acquire Nexcelom Bioscience for US$ 260 million

Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for-purpose cell counting method selection and development instructions that follow ISO Cell Counting Standards and aid in the development of cell and gene and immuno-oncology therapies

Pharma Acquisition | 14/05/2021 | By Darshana |  306